Published in Blood Weekly, June 3rd, 2010
Domestic sales accounted for 88.2% and 78.8% of the revenues for the three months ended March 31, 2010 and 2009, respectively. International sales accounted for the remaining revenues. Domestic revenues increased 80.1% principally due to higher average prices and higher volumes. Most of the increase in domestic revenues is attributable to sales of the 1mL and 3mL syringes. International revenues decreased 10.1% due primarily to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.